Yondelis (trabectedin)

pCPA File Number: 23620
Negotiation Status:
Active Negotiation
Indication(s):
in combination with doxorubicin as first-line treatment for advanced unresectable
or metastatic uterine or soft tissue leiomyosarcoma
Sponsor/Manufacturer:
Xediton Pharmaceuticals Inc
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded:
Not Applicable